Company Number: 14721203

Analysis Date: 2025-07-20 18:47 UTC

Financial Health Assessment for COLLABRADOR LIMITED

---

1. Financial Health Score: D

Explanation:
The company is currently showing significant financial stress, reflected by negative net assets and a large working capital deficiency. As a micro-entity in its first year of trading, the negative equity and liquidity shortfall are concerning "symptoms" indicating financial instability. However, as a newly incorporated entity, these issues may partly reflect early-stage investment and startup costs, not yet stabilized revenues.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets (Intangible)	98,583	Indicates investment in intangible assets (e.g., software, IP). This can be a valuable resource but is less liquid.
Current Assets	14,760	Cash, receivables, and other short-term assets. Relatively low liquidity “blood flow”.
Current Liabilities	138,677	Short-term debts due within a year. High level compared to current assets, causing liquidity strain.
Net Current Assets	-123,917	Negative working capital, a “symptom of distress” where short-term obligations exceed available liquid resources.
Total Assets Less Current Liabilities	-25,334	Negative overall asset coverage after accounting for short-term liabilities.
Net Assets (Equity)	-25,334	Negative shareholders’ funds, indicating liabilities exceed assets — a critical “diagnostic red flag.”
Share Capital	10	Minimal paid-in capital, typical for a startup but insufficient to buffer losses or debts.

---

3. Diagnosis

The financial “vital signs” suggest COLLABRADOR LIMITED is currently in a fragile state. The large negative working capital and negative net assets are akin to a patient with poor circulation and weakened vital organs — the company lacks sufficient liquid resources to comfortably meet its short-term obligations. The intangible assets are significant but illiquid, offering little immediate relief to cash flow challenges.

Given the company was incorporated recently (March 2023) and these accounts reflect the first 12 months, the “symptoms” may be typical startup challenges: high upfront costs and investment in intangible assets before revenue ramps up. However, without a clear path to improving liquidity and profitability, this financial condition will worsen, risking insolvency.

---

4. Recommendations

To improve the financial wellness of COLLABRADOR LIMITED, the directors should consider the following "treatment plan":

• Boost Liquidity: Seek additional working capital injections, either via shareholder loans, equity investment, or short-term financing facilities, to ease the liquidity crunch.
• Cost Management: Review and strictly control operating expenses to preserve cash flow. Delay or reduce discretionary spending.
• Monetize Intangibles: Explore opportunities to license or sell parts of intangible assets where possible to generate cash.
• Revenue Generation: Accelerate sales and contracts to improve incoming cash flow — the “heartbeat” of the business.
• Financial Monitoring: Implement robust cash flow forecasting and regular financial health checks to detect worsening symptoms early.
• Professional Advice: Engage a financial advisor or turnaround specialist to assist with restructuring if cash flow does not improve.

---

Executive Summary